ATYR
Atyr Pharma, Inc.
Clinical-stage biotherapeutics company focused on tRNA synthetase biology
CUSIP: 002120103HealthcareUS1 holder
Total Value
$8.98M
Total Shares
1.78M
Net Share Change
+1.78M
Activity
1 buying
Investor
Value
Shares
Weight
Change
Viking Global Investors
$8.98M1.78M sharesNEW